EKSO:NASDAQ
Ekso Bionics Holdings Inc
$12.01
arrow_upward
+4.98%(+0.57) 1 日
$12.01
0.00% (0.00)
bedtime時間外取引
終了: 4月30日, 16:00:01 GMT-4 · USD
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoEKSO の上位の分析情報を生成しています...
始値
$11.45
高値
$12.28
安値
$11.45
時価総額
4279.62万
平均出来高
7.31万
取引量
4.50万
52 週高値
$13.50
52 週安値
$2.75
EPS
-$4.91
ベータ版
0.78
発行済株式数
356.30万
従業員数
50
ニュース記事
ウェブの情報から
kare11.com
·
1 日前
Ekso Bionics: Q1 Earnings Snapshot
プロフィール
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Ekso Bionics Holdings Inc について